SCHEMBL8619733

SCHEMBL8619733

CCC(C)Cc1ccc(-c2cc(C(=O)NC(=N)N)c3ccccc3n2)cc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 2/20 0.58
TACR3 P29371 11/20 0.53
TACR2 P21452 2/20 0.53
KDM4E B2RXH2 4/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
ALDH1A1 P00352 2/20 0.52
MEN1 O00255 2/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
KMT2A Q03164 2/20 0.52
MITF O75030 1/20 0.52
PKM P14618 1/20 0.52
TSHR P16473 1/20 0.50
LMNA P02545 3/20 0.49
HPGD P15428 2/20 0.49
TP53 P04637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8615299 0.91 TACR3 (0.49) DHODHTACR3TACR2KDM4EALDH1A1
SCHEMBL8615123 0.89 DHODH (0.59) DHODHTACR3TACR2KDM4ESMN1; SMN2
SCHEMBL8616485 0.86 LMNA (0.58) TACR3TACR2KDM4ESMN1; SMN2ALDH1A1
SCHEMBL8617740 0.84 TACR3 (0.51) DHODHTACR3TACR2KDM4EMEN1
SCHEMBL8618946 0.83 DHODH (0.56) DHODHTACR3KDM4ESMN1; SMN2ALDH1A1
SCHEMBL8619720 0.83 TACR3 (0.52) DHODHTACR3TACR2KDM4ESMN1; SMN2
SCHEMBL8617743 0.83 CYP3A4 (0.65) DHODHTACR3KDM4ESMN1; SMN2ALDH1A1
SCHEMBL8614044 0.83 TACR3 (0.46) TACR3TACR2KDM4EALDH1A1TSHR
SCHEMBL8619214 0.82 KDM4E (0.52) DHODHTACR3TACR2KDM4ESMN1; SMN2
SCHEMBL8615354 0.82 CYP3A4 (0.65) TACR3KDM4ESMN1; SMN2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed